The innovative crisis is a consequence of scientific stagnation in pharmaceutical research. As a result of innovative crisis the number of innovative drugs put on the market has decreased. Biopharmaceutical research methods combined with findings in molecular mechanism of diseases will allow the discovery of new innovative diagnostics and drugs.

What’s in your product? Come hear the latest advances in the field of biopharmaceutical HCP Testing ● Rare Reagents: Multiple Case Studies on how to develop your rare reagents, including selection of null cell lines, developing immunization strategies and assessing the specificity of your antibodies, characterization of antibodies and standards by 2-D Gels, western blots, and immunofractionation

Introduction. The presence of biologically active substances in the extract from roots turmeric ( Curcuma longa L.) makes it reasonable and possible to predict their effectiveness pathological conditions caused by oxidative stress immune disorders arising against its background. Based on data obtained, a pattern was revealed improving solubility combination methionine extract, which includes au...

Abstract It is well documented that the biopharmaceutical sector has exhibited weak financial returns, contributing to underinvestment. Innovations in industry carry high risks; however, an analysis of systematic risk and return compared other asset classes missing. This paper investigates time–frequency interconnectedness between stocks biotech ten using daily cross-country data from 1995 2019...

Process models are mathematical formulations (essentially a set of equations) that try to represent the real system/process in digital or virtual form. These derived either based on fundamental physical laws often combined with empirical assumptions learned data. The former has been existing for several decades chemical and process engineering while latter recently received lot attention emerge...